<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ayanlade JP</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>11-18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11701928</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>81(Pt 1)</volume><pubmed_abstract>Helicobacter pylori, a type 1 carcinogen that causes human gastric ulcers and cancer, is a priority target of the Seattle Structural Genomics Center for Infectious Disease (SSGCID). These efforts include determining the structures of potential H. pylori therapeutic targets. Here, the purification, crystallization and X-ray structure of one such target, H. pylori biotin protein ligase (HpBPL), are reported. HpBPL catalyzes the activation of various biotin-dependent metabolic pathways, including fatty-acid synthesis, gluconeogenesis and amino-acid catabolism, and may facilitate the survival of H. pylori in the high-pH gastric mucosa. HpBPL is a prototypical bacterial biotin protein ligase, despite having less than 35% sequence identity to any reported structure in the Protein Data Bank. A bi</pubmed_abstract><journal>Acta crystallographica. Section F, Structural biology communications</journal><pubmed_title>Co-crystal structure of Helicobacter pylori biotin protein ligase with biotinyl-5-ATP.</pubmed_title><pmcid>PMC11701928</pmcid><funding_grant_id>R25CA250956</funding_grant_id><funding_grant_id>75N93022C00036</funding_grant_id><funding_grant_id>R25 CA250956</funding_grant_id><pubmed_authors>Dranow DM</pubmed_authors><pubmed_authors>Lorimer DD</pubmed_authors><pubmed_authors>Hammerson B</pubmed_authors><pubmed_authors>Ayanlade JP</pubmed_authors><pubmed_authors>Myler PJ</pubmed_authors><pubmed_authors>Davis DE</pubmed_authors><pubmed_authors>Asojo OA</pubmed_authors><pubmed_authors>Subramanian S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Co-crystal structure of Helicobacter pylori biotin protein ligase with biotinyl-5-ATP.</name><description>Helicobacter pylori, a type 1 carcinogen that causes human gastric ulcers and cancer, is a priority target of the Seattle Structural Genomics Center for Infectious Disease (SSGCID). These efforts include determining the structures of potential H. pylori therapeutic targets. Here, the purification, crystallization and X-ray structure of one such target, H. pylori biotin protein ligase (HpBPL), are reported. HpBPL catalyzes the activation of various biotin-dependent metabolic pathways, including fatty-acid synthesis, gluconeogenesis and amino-acid catabolism, and may facilitate the survival of H. pylori in the high-pH gastric mucosa. HpBPL is a prototypical bacterial biotin protein ligase, despite having less than 35% sequence identity to any reported structure in the Protein Data Bank. A bi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T18:28:46.963Z</modification><creation>2026-04-18T03:13:45.286Z</creation></dates><accession>S-EPMC11701928</accession><cross_references><pubmed>39704719</pubmed><doi>10.1107/S2053230X24012056</doi></cross_references></HashMap>